Combination of nanotechnology with vascular targeting agents for effective cancer therapy.

Jahanban-Esfahlan R, Seidi K, Banimohamad-Shotorbani B, Jahanban-Esfahlan A, Yousefi B

DOI: 10.1002/jcp.26051
Published: 2018 Apr
Container: Journal of cellular physiology
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcp.26051,
  title = {Combination of nanotechnology with vascular targeting agents for effective cancer therapy.},
  author = {Jahanban-Esfahlan R and Seidi K and Banimohamad-Shotorbani B and Jahanban-Esfahlan A and Yousefi B},
  year = {2018},
  journal = {Journal of cellular physiology},
  doi = {10.1002/jcp.26051},
  url = {https://doi.org/10.1002/jcp.26051}
}

RIS

TY  - JOUR
TI  - Combination of nanotechnology with vascular targeting agents for effective cancer therapy.
AU  - Jahanban-Esfahlan R
AU  - Seidi K
AU  - Banimohamad-Shotorbani B
AU  - Jahanban-Esfahlan A
AU  - Yousefi B
PY  - 2018
JO  - Journal of cellular physiology
DO  - 10.1002/jcp.26051
UR  - https://doi.org/10.1002/jcp.26051
ER  -

APA

R, J., K, S., B, B., A, J., & B, Y. (2018). Combination of nanotechnology with vascular targeting agents for effective cancer therapy.. Journal of cellular physiology. https://doi.org/10.1002/jcp.26051

Source records

pubmed · retrieved 2026-09-25T13:20:09.419Z
europe-pmc · retrieved 2026-09-25T13:20:09.423Z